Diamond-Blackfan Anemia 6

Search Trials
Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies
Status:
Recruiting
Last Changed:
Apr 12, 2022
First Changed:
Jul 1, 2014
Disease(s):
Sickle Cell Disease
Intervention(s):
Reduced Toxicity Ablative RegimenReduced Intensity Preparative RegimenMyeloablative Preparative Regimen
CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation
Status:
Active, not recruiting
Last Changed:
Jun 19, 2020
First Changed:
Oct 21, 2013
Disease(s):
Bone Marrow Failure Syndrome
Intervention(s):
CD34 Stem Cell Selection Therapy
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
Status:
Recruiting
Last Changed:
Apr 13, 2022
First Changed:
Nov 7, 2017
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Intervention(s):
CyclophosphamideFludarabine PhosphateLaboratory Biomarker AnalysisPeripheral Blood Stem Cell TransplantationTotal-Body Irradiation
Familial Investigations of Childhood Cancer Predisposition
Status:
Recruiting
Last Changed:
May 13, 2022
First Changed:
Feb 10, 2017
Disease(s):
Acute Leukemia
Cancer in Inherited Bone Marrow Failure Syndromes
Status:
Recruiting
Last Changed:
Jul 12, 2022
First Changed:
Nov 30, 2001
Disease(s):
Diamond Blackfan Anemia

Connect. Empower. Inspire.